Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis

Yago Nieto; Stephen Gruschkus; Benigno C. Valdez; Roy B. Jones; Paolo Anderlini; Chitra Hosing; Uday Popat; Muzaffar Qazilbash; Partow Kebriaei; Amin Alousi; Neeraj Saini; Samer Srour; Katayoun Rezvani; Jeremy Ramdial; Melissa Barnett; Alison Gulbis; Terri Lynn Shigle; Sairah Ahmed; Swaminathan Iyer; Hun Lee; Ranjit Nair; Simrit Parmar; Raphael Steiner; Bouthaina Dabaja; Chelsea Pinnix; Jillian Gunther; Branko Cuglievan; Kris Mahadeo; Sajad Khazal; Hubert Chuang; Richard Champlin; Elizabeth J. Shpall; Borje S. Andersson

doi:10.3324/haematol.2021.278311

Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis

Yago Nieto
, Stephen Gruschkus
, Benigno C. Valdez
, Roy B. Jones
, Paolo Anderlini
, Chitra Hosing
, Uday Popat
, Muzaffar Qazilbash
, Partow Kebriaei
, Amin Alousi
, Neeraj Saini
, Samer Srour
, Katayoun Rezvani
, Jeremy Ramdial
, Melissa Barnett
, Alison Gulbis
, Terri Lynn Shigle
, Sairah Ahmed
, Swaminathan Iyer
, Hun Lee

Ranjit Nair, Simrit Parmar, Raphael Steiner, Bouthaina Dabaja, Chelsea Pinnix, Jillian Gunther, Branko Cuglievan, Kris Mahadeo, Sajad Khazal, Hubert Chuang, Richard Champlin, Elizabeth J. Shpall, Borje S. Andersson

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	899-908
Number of pages	10
Journal	Haematologica
Volume	107
Issue number	4
DOIs	https://doi.org/10.3324/haematol.2021.278311
State	Published - Apr 2022
Externally published	Yes

ASJC Scopus Subject Areas

Hematology

Keywords

Humans
Retrospective Studies
Brentuximab Vedotin
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Hodgkin Disease/diagnosis
Neoplasm Recurrence, Local/pathology

Access to Document

10.3324/haematol.2021.278311

OpenUrl availability

Full text

Cite this

Nieto, Y., Gruschkus, S., Valdez, B. C., Jones, R. B., Anderlini, P., Hosing, C., Popat, U., Qazilbash, M., Kebriaei, P., Alousi, A., Saini, N., Srour, S., Rezvani, K., Ramdial, J., Barnett, M., Gulbis, A., Shigle, T. L., Ahmed, S., Iyer, S., ... Andersson, B. S. (2022). Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica, 107(4), 899-908. https://doi.org/10.3324/haematol.2021.278311

Nieto, Y, Gruschkus, S, Valdez, BC, Jones, RB, Anderlini, P, Hosing, C, Popat, U, Qazilbash, M, Kebriaei, P, Alousi, A, Saini, N, Srour, S, Rezvani, K, Ramdial, J, Barnett, M, Gulbis, A, Shigle, TL, Ahmed, S, Iyer, S, Lee, H, Nair, R, Parmar, S, Steiner, R, Dabaja, B, Pinnix, C, Gunther, J, Cuglievan, B, Mahadeo, K, Khazal, S, Chuang, H, Champlin, R, Shpall, EJ & Andersson, BS 2022, 'Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis', Haematologica, vol. 107, no. 4, pp. 899-908. https://doi.org/10.3324/haematol.2021.278311

@article{d3a156422fcc4f9cb6908b93a07466b4,

title = "Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis",

keywords = "Humans, Retrospective Studies, Brentuximab Vedotin, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Hodgkin Disease/diagnosis, Neoplasm Recurrence, Local/pathology",

author = "Yago Nieto and Stephen Gruschkus and Valdez, \{Benigno C.\} and Jones, \{Roy B.\} and Paolo Anderlini and Chitra Hosing and Uday Popat and Muzaffar Qazilbash and Partow Kebriaei and Amin Alousi and Neeraj Saini and Samer Srour and Katayoun Rezvani and Jeremy Ramdial and Melissa Barnett and Alison Gulbis and Shigle, \{Terri Lynn\} and Sairah Ahmed and Swaminathan Iyer and Hun Lee and Ranjit Nair and Simrit Parmar and Raphael Steiner and Bouthaina Dabaja and Chelsea Pinnix and Jillian Gunther and Branko Cuglievan and Kris Mahadeo and Sajad Khazal and Hubert Chuang and Richard Champlin and Shpall, \{Elizabeth J.\} and Andersson, \{Borje S.\}",

note = "Publisher Copyright: {\textcopyright} 2022 Ferrata Storti Foundation.",

year = "2022",

month = apr,

doi = "10.3324/haematol.2021.278311",

language = "English",

volume = "107",

pages = "899--908",

journal = "Haematologica",

issn = "0390-6078",

number = "4",

}

TY - JOUR

T1 - Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy

T2 - a 15-year analysis

AU - Nieto, Yago

AU - Gruschkus, Stephen

AU - Valdez, Benigno C.

AU - Jones, Roy B.

AU - Anderlini, Paolo

AU - Hosing, Chitra

AU - Popat, Uday

AU - Qazilbash, Muzaffar

AU - Kebriaei, Partow

AU - Alousi, Amin

AU - Saini, Neeraj

AU - Srour, Samer

AU - Rezvani, Katayoun

AU - Ramdial, Jeremy

AU - Barnett, Melissa

AU - Gulbis, Alison

AU - Shigle, Terri Lynn

AU - Ahmed, Sairah

AU - Iyer, Swaminathan

AU - Lee, Hun

AU - Nair, Ranjit

AU - Parmar, Simrit

AU - Steiner, Raphael

AU - Dabaja, Bouthaina

AU - Pinnix, Chelsea

AU - Gunther, Jillian

AU - Cuglievan, Branko

AU - Mahadeo, Kris

AU - Khazal, Sajad

AU - Chuang, Hubert

AU - Champlin, Richard

AU - Shpall, Elizabeth J.

AU - Andersson, Borje S.

PY - 2022/4

Y1 - 2022/4

KW - Humans

KW - Retrospective Studies

KW - Brentuximab Vedotin

KW - Antineoplastic Combined Chemotherapy Protocols/adverse effects

KW - Hodgkin Disease/diagnosis

KW - Neoplasm Recurrence, Local/pathology

UR - https://www.scopus.com/pages/publications/85127939724

UR - https://www.scopus.com/pages/publications/85127939724#tab=citedBy

UR - https://www.mendeley.com/catalogue/48ca2988-aaa2-39cd-9cb4-db71ffe05742/

U2 - 10.3324/haematol.2021.278311

DO - 10.3324/haematol.2021.278311

M3 - Article

C2 - 33951890

AN - SCOPUS:85127939724

SN - 0390-6078

VL - 107

SP - 899

EP - 908

JO - Haematologica

JF - Haematologica

IS - 4

ER -

Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this